CYCC — Stock activity · TradeandTellCYCC
CYCC
$6.37-$0.40 (-5.98%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$5.92 – $9.40
13% from low
Held by traders on TradeandTell
No one on the platform currently holds CYCC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CYCC as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.36% ($0.15/share)
| Ex-date | Per share | Pay date |
|---|
| 2025-04-29 | $0.1500 | 2025-05-01 |
Stock splits
| Execution date | Ratio |
|---|
| 2023-12-18 | 1-for-15reverse |
| 2020-04-15 | 1-for-20reverse |
| 2016-05-31 | 1-for-12reverse |
| 2012-08-27 | 1-for-7reverse |
Recent trades on TradeandTell
No one on the platform has traded CYCC yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $100000 | +0.0% | $-268.80 | $-268.80–$-268.80 | — | 1 |
| 2027 | $81M | +80482.0% | $880.80 | $880.80–$880.80 | 0.0× | 1 |
| 2028 | $118M | +46.5% | $1317.60 | $1317.60–$1317.60 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2025-11-13 | $-72.00 | $-0.00 | +100.0% |
| 2025-08-13 | $-72.00 | $-0.98 | +98.6% |
| 2025-05-15 | $-69.60 | $-6.25 | +91.0% |
| 2025-04-02 | $-4.64 | $-5.28 | -13.8% |
| 2024-11-12 | $-0.54 | $-0.18 | +66.7% |
| 2024-08-14 | $-0.83 | $-0.72 | +13.3% |
| 2024-05-14 | $-4.93 | $-2.27 | +54.0% |
| 2024-03-19 | $-6.35 | $-6.23 | +1.9% |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| CYCCCyclacel Pharmaceuticals, Inc. | $6.37 | -5.98% | $11M | — |
| AMTIApplied Molecular Transport Inc. | $0.26 | -3.13% | $11M | — |
| APGNApexigen, Inc. | $0.39 | +8.48% | $10M | — |
| EPIXESSA Pharma Inc. | $0.20 | -1.85% | $10M | — |
| GLSGelesis Holdings, Inc. | $0.16 | +0.00% |
| IMVIFIMV Inc. | $0.00 | +0.00% | $23423 | — |
| KRROKorro Bio, Inc. | $13.29 | -0.45% | $132M | — |
Source: Financial Modeling Prep · peers by sector/industry